Security key
88025U109
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)
CUSIP: 88025U109
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Total 13F shares
- 105,353,108
- Total 13F value
- $2,048,895,776
- Share change
- +3,614,411
- Put/Call ratio
- 66%
- SEC-reported price per share
- $19.45
- Number of holders
- 254
- Value change
- +$7,101,276
- Number of buys
- 143
- Number of sells
- 134
- Shares outstanding
- 120,172,375
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
254
Top holders
10
TXG full security history
Ownership snapshot
Full 13F holder table
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $485,234,732
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $485.23M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$485.23M
VANGUARD GROUP INC
$341.58M
BAILLIE GIFFORD & CO
$278.65M
ARK Investment Management LLC
$235.83M
BlackRock Finance, Inc.
$225.47M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$485,234,732
12,929,249 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$341,580,647
9,101,536 shares
|
— | 31 Mar 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$278,651,467
7,424,766 shares
|
— | 31 Mar 2024 |
| ARK Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$235,831,466
6,283,812 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$225,466,842
6,007,643 shares
|
— | 31 Mar 2024 |
| Bryan E. Roberts |
3/4/5
Director
|
—
mixed-class rows
|
$195,830,277
4,294,791 shares
mixed-class rows
|
— | 14 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
254
Shares
105,353,108
Rows available
254
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
280
Q2 2024 holders
254
Holder diff
-26
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|